INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

RAREUltragenyx Pharmaceutical Inc.

CIK 0001515673

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells3 / 0
Max Insider Score24
Connections8with evidence

RARE · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
Gilbert Ray Cisneros, Jr.DSelf
RAREUltragenyx Pharmaceutical Inc.
Purchase
BUY$1,001 – $15KSep 29, 2026Oct 12, 2026
traded Sep 29, 2026
+13dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)FEC Form 1 connected organization: ULTRAGENYX PHARMACEUTICAL INC. (exact legal-name match) · Nov 4, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-10-12 · Oct 12, 2026
  • ← Lobbied forevidence
    FORBES-TATE
24
Gilbert Ray Cisneros, Jr.DSelf
RAREUltragenyx Pharmaceutical Inc.
Purchase
BUY
$1,001 – $15K
Mar 3, 2026
Apr 7, 2026
traded Mar 3, 2026
+35d
HOUSE PTR

Evidence

24
Gilbert Ray Cisneros, Jr.DSelf
RAREUltragenyx Pharmaceutical Inc.
Purchase
BUY$1,001 – $15KFeb 18, 2026Mar 9, 2026
traded Feb 18, 2026
+19dHOUSE PTR

Evidence

LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    AVIVA STRATEGIES (FKA MGB CONSULTING)LDA 1T 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    ALPINE GROUP PARTNERS, LLC.LDA Q2 2026 second quarter · Health issues, Government issues, MED · Aug 26, 2026
  • ← Lobbied forevidence
    MEHLMAN CONSULTING, INC.LDA Q2 2026 second quarter · Health issues, Budget/appropriations · Aug 26, 2026
  • ← Lobbied forevidence
    MILLER STRATEGIES, LLCLDA RR 2026 first quarter · MED · Aug 26, 2026

    • Lobbying

    $830K reported · de-duplicated
    2026 Q2 $390K in-house2026 Q1 $440K in-house
    • ALPINE GROUP PARTNERS, LLC.—2026 Q1 · posted Aug 26, 2026 · Health issues, Government issues, MED
    • FORBES-TATE—2026 Q1 · posted Aug 26, 2026 · Health issues
    • MILLER STRATEGIES, LLC—2026 Q1 · posted Aug 26, 2026 · MED
    • In-house report$390K2026 Q2 · posted Aug 26, 2026 · Health issues, Budget/appropriations, Medicare/Medicaid
    • In-house report$440K2026 Q1 · posted Aug 26, 2026 · Health issues, Budget/appropriations, Medicare/Medicaid
    • FORBES-TATE$10K2026 Q1 · posted Aug 26, 2026 · Health issues
    • MILLER STRATEGIES, LLC—2026 Q1 · posted Aug 26, 2026 · MED
    • ALPINE GROUP PARTNERS, LLC.$40K2026 Q1 · posted Aug 26, 2026 · Health issues, Government issues, MED
    • MILLER STRATEGIES, LLC$140K2026 Q2 · posted Aug 26, 2026 · MED
    • AVIVA STRATEGIES (FKA MGB CONSULTING)—2026 Q1 · posted Aug 26, 2026 · Health issues
    • ALPINE GROUP PARTNERS, LLC.$60K2026 Q2 · posted Aug 26, 2026 · Health issues, Government issues, MED
    • MEHLMAN CONSULTING, INC.$60K2026 Q2 · posted Aug 26, 2026 · Health issues, Budget/appropriations

    Connected PAC contributions

    FEC · direct to members
    • Doris O. MatsuiD$6,500ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
    • Kevin MullinD$6,500ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
    • Diana DeGetteD$5,000ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
    • Lateefah SimonD$2,500ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
    • Gus M. BilirakisR$2,500
    ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
  • Earl L. "Buddy" CarterR$2,500ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
  • Lori TrahanD$2,500ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
  • Bill CassidyR$2,000ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
  • Ashley MoodyR$2,000ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
  • Roger MarshallR$2,000ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
  • H. Morgan GriffithR$2,000ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)
  • Jake AuchinclossD$1,000ULTRAGENYX PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE (AKA ULTRAGENYX PAC)